Tuesday, November 5, 2024
HomeTagsRare hematologic disorder

rare hematologic disorder

FDA Approves AYVAKIT as the First and Only Treatment for Indolent Systemic Mastocytosis

Blueprint Medicines Corporation announced that the U.S. Food and Dru Administration (FDA) has approved AYVAKIT (avapritinib) for the treatment of adults with indolent systemic mastocytosis (ISM)....
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics